FDA Inspection 625848 — Amphastar France Pharmaceuticals
The FDA completed an inspection of Amphastar France Pharmaceuticals on October 20, 2009 in Eragny Sur Epte. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 20, 2009
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Eragny Sur Epte (France)